NICE has been developing an antimicrobial prescribing guideline on diabetic foot infection. The diabetic foot infection recommendations for antimicrobial prescribing will update and replace the existing NICE guideline on diabetic foot problems: prevention and management (section on treating diabetic foot infection only Recommendations 1.6.6 -15). The update of the antimicrobial prescribing recommendations in the diabetic foot problems guideline is scheduled to publish on 11 October 2019.

You can now review and comment on this draft guideline. 

The consultation closes on 16 May 2019 at 5pm

How to comment

1. Register your organisation

Your organisation needs to be registered as a stakeholder before we can accept comments. Please register as a stakeholder for ‘Managing common infections’

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

2. Read the consultation documents

Visual summary of the recommendations

Our recommendations

The evidence

Other information about the consultation

3. Add your comments

  • You must use this form.
  • You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Specific questions:

  • For the guideline:
    • Are there any recommendations that will be a significant change to practice or will be difficult to implement? If so, please give reasons why.
    • What are the key issues or learning points for professional groups?

Make sure you consider:

  • The areas that will have the biggest impact on practice and be challenging to implement
  • How to help users overcome challenges

Related guidance in this area:

In addition, for your information there are ongoing surveillance reviews on:

  • Diabetic foot problems: prevention and management

This is taking place to understand if other parts of the diabetic foot problems guideline need updating. 

  • Type 1 diabetes in adults: diagnosis and management (NG17)
  • Diabetes (Type 1 and 2) in children and young people: diagnosis and management (NG18)
  • Type 2 diabetes in adults: management (NG28)

The consultation on the surveillance proposals for these 4 guidelines will run from the 25 April to 9 May 2019

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us


Deadline: 16 May 2019 at 5pm

This page was last updated: